François-Xavier Danlos (Francois-Xavier Danlos, François Xavier Danlos)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Escherichia Coli

Muscle Invasive Bladder Cancer

Epidermal Growth Factor Receptor

Acute Lymphoblastic Leukemia

Top Venues

Journal for immunotherapy of cancer

JCO precision oncology

Cancer discovery

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Ronan Flippot, Marcus Teixeira, Macarena Rey-Cardenas, Lucía Carril-Ajuria, Larissa Rainho, Natacha Naoun, Jean-Mehdi Jouniaux, Lisa Boselli, Marie Naigeon, François-Xavier Danlos, Bernard Escudier, Jean-Yves Scoazec, Lydie Cassard, Laurence Albiges, Nathalie Chaput
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors. Journal for immunotherapy of cancer 12 (4) (2024)
Laurent Mathiot, David Combarel, Justin Cagnat, Julia Delahousse, Kaissa Ouali, Aurélien Marabelle, Yohann Loriot, Santiago Ponce, Stephane Champiat, Sophie Broutin, François-Xavier Danlos
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors. Journal for immunotherapy of cancer 12 (5) (2024)
Julieta Rodriguez, Capucine Baldini, Arnauld Bayle, Arnaud Pagès, François-Xavier Danlos, Damien Vasseur, Etienne Rouleau, Ludovic Lacroix, Beatriz Alonso de Castro, Vincent Goldschmidt, Lauren Seknazi, Antoine Hollebecque, Jean Marie Michot, Stephane Champiat, Aurélien Marabelle, Kaissa Ouali, Christophe Marzac, Santiago Ponce, Jean-Baptiste Micol, Nathalie Chaput, Christophe Massard, Antoine Italiano
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial. JCO precision oncology 8 (2024)
Ronan Flippot, Marcus Teixeira, Macarena Rey-Cardenas, Lucía Carril-Ajuria, Larissa Rainho, Natacha Naoun, Jean-Mehdi Jouniaux, Lisa Boselli, Marie Naigeon, François-Xavier Danlos, Bernard Escudier, Jean-Yves Scoazec, Lydie Cassard, Laurence Albiges, Nathalie Chaput
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors. Journal for immunotherapy of cancer 12 (4) (2024)
Julieta Rodriguez, Capucine Baldini, Arnauld Bayle, Arnaud Pagès, François-Xavier Danlos, Damien Vasseur, Etienne Rouleau, Ludovic Lacroix, Beatriz Alonso de Castro, Vincent Goldschmidt, Lauren Seknazi, Antoine Hollebecque, Jean Marie Michot, Stephane Champiat, Aurélien Marabelle, Kaissa Ouali, Christophe Marzac, Santiago Ponce, Jean-Baptiste Micol, Nathalie Chaput, Christophe Massard, Antoine Italiano
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial. JCO precision oncology 8 (2024)
Ronan Flippot, Marcus Teixeira, Macarena Rey-Cardenas, Lucía Carril-Ajuria, Larissa Rainho, Natacha Naoun, Jean-Mehdi Jouniaux, Lisa Boselli, Marie Naigeon, François-Xavier Danlos, Bernard Escudier, Jean-Yves Scoazec, Lydie Cassard, Laurence Albiges, Nathalie Chaput
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors. Journal for immunotherapy of cancer 12 (4) (2024)
Ronan Flippot, Marcus Teixeira, Macarena Rey-Cardenas, Lucía Carril-Ajuria, Larissa Rainho, Natacha Naoun, Jean-Mehdi Jouniaux, Lisa Boselli, Marie Naigeon, François-Xavier Danlos, Bernard Escudier, Jean-Yves Scoazec, Lydie Cassard, Laurence Albiges, Nathalie Chaput
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors. Journal for immunotherapy of cancer 12 (4) (2024)
Laurent Mathiot, David Combarel, Justin Cagnat, Julia Delahousse, Kaissa Ouali, Aurélien Marabelle, Yohann Loriot, Santiago Ponce, Stephane Champiat, Sophie Broutin, François-Xavier Danlos
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors. Journal for immunotherapy of cancer 12 (5) (2024)
Michele Bottosso, Benjamin Verret, Olivier Caron, Nadim Hamzaoui, Éric Pasmant, François-Xavier Danlos, Pascaline Boudou-Rouquette, Arunya Srikaran, Hélène Blons, Valentina Guarneri, Sherene Loi, Fabrice Andre, Camille Tlemsani
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO precision oncology 8 (2024)
Ronan Flippot, Marcus Teixeira, Macarena Rey-Cardenas, Lucía Carril-Ajuria, Larissa Rainho, Natacha Naoun, Jean-Mehdi Jouniaux, Lisa Boselli, Marie Naigeon, François-Xavier Danlos, Bernard Escudier, Jean-Yves Scoazec, Lydie Cassard, Laurence Albiges, Nathalie Chaput
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors. Journal for immunotherapy of cancer 12 (4) (2024)
Laurent Mathiot, David Combarel, Justin Cagnat, Julia Delahousse, Kaissa Ouali, Aurélien Marabelle, Yohann Loriot, Santiago Ponce, Stephane Champiat, Sophie Broutin, François-Xavier Danlos
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors. Journal for immunotherapy of cancer 12 (5) (2024)
Laurent Mathiot, David Combarel, Justin Cagnat, Julia Delahousse, Kaissa Ouali, Aurélien Marabelle, Yohann Loriot, Santiago Ponce, Stephane Champiat, Sophie Broutin, François-Xavier Danlos
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors. Journal for immunotherapy of cancer 12 (5) (2024)
Marine Fidelle, Conrad Rauber, Carolina Alves Costa Silva, Ai-Ling Tian, Imran Lahmar, Anne-Laure Mallard de La Varende, Liwei Zhao, Cassandra Thelemaque, Isabelle Lebhar, Meriem Messaoudene, Eugenie Pizzato, Roxanne Birebent, Maxime Descartes Mbogning Fonkou, Silvia Zoppi, Anna Reni, Cécile Dalban, Marion Leduc, Gladys Ferrere, Sylvère Durand, Pierre Ly, Aymeric Silvin, Kevin Mulder, Charles-Antoine Dutertre, Florent Ginhoux, Satoru Yonekura, Maria Paula Roberti, Maryam Tidjani Alou, Safae Terrisse, Jianzhou Chen, Oliver Kepp, Angela Schippers, Norbert Wagner, Javier Suarez-Gosalvez, Sebastian Kobold, Jean-Eudes Fahrner, Corentin Richard, Jacques Bosq, Leonardo Lordello, Giacomo Vitali, Nathalie Galleron, Benoit Quinquis, Emmanuelle Le Chatelier, Lucas Blanchard, Jean-Philippe Girard, Anne Jarry, Nadine Gervois-Segain, Emmanuelle Godefroy, Nathalie Labarrière, Ronald Koschny, Romain Daillère, Benjamin Besse, Caroline Truntzer, François Ghiringhelli, Nicolas Coatnoan, Vanessa Mhanna, David Klatzmann, Damien Drubay, Laurence Albiges, Andrew Maltez Thomas, Nicola Segata, François-Xavier Danlos, Aurélien Marabelle, Bertrand Routy, Lisa Derosa, Guido Kroemer, Laurence Zitvogel
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. Science (New York, N.Y.) 380 (6649) (2023)
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, Lisa Boselli, Jean-Mehdi Jouniaux, Caroline de Oliveira, Roberto Ferrara, Boris Duchemann, Caroline Berthot, Lou Girard, Ronan Flippot, Laurence Albiges, Siham Farhane, Patrick Saulnier, Ludovic Lacroix, Frank Griscelli, Gabriel Roman, Tyler Hulett, Aurélien Marabelle, Lydie Cassard, Benjamin Besse, Nathalie Chaput
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8 + T cells in patients with advanced NSCLC. Science advances 9 (45) (2023)
François-Xavier Danlos, Matthieu Texier, Bastien Job, Séverine Mouraud, Lydie Cassard, Capucine Baldini, Andrea Varga, Andrey A Yurchenko, Audrey Rabeau, Stephane Champiat, Diane Letourneur, Delphine Bredel, Sandrine Susini, Yuna Blum, Aurelien Parpaleix, Cedric Parlavecchio, Lambros Tselikas, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, Mathieu Rouanne, Saloomeh Rafie, Alae Abbassi, Ines Kasraoui, Marie Breckler, Siham Farhane, Samy Ammari, Salim Laghouati, Anas Gazzah, Ludovic Lacroix, Benjamin Besse, Nathalie M Droin, Marc Deloger, Sophie Cotteret, Julien Adam, Laurence Zitvogel, Sergey I Nikolaev, Nathalie Chaput, Christophe Massard, Jean-Charles Soria, Carlos Alberto Gomez Roca, Gérard Zalcman, David Planchard, Aurélien Marabelle
Genomic Instability and Pro-Tumoral Inflammation are associated with Primary Resistance to Anti-PD1 + Anti-Angiogenesis in Malignant Pleural Mesothelioma. Cancer discovery (2023)
Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, Isabelle Peguillet, Marianne Gazzano, Maxime Descartes Mbogning Fonkou, Cassandra Thelemaque, Cedric Lebacle, Constance Thibault, Francois Audenet, Géraldine Pignot, Gwenaëlle Gravis, Carole Helissey, Luca Campedel, Morgan Roupret, Evanguelos Xylinas, Idir Ouzaid, Agathe Dubuisson, Marine Mazzenga, Caroline Flament, Pierre Ly, Virginie Marty, Nicolas Signolle, Allan Sauvat, Thomas Sbarrato, Mounia Filahi, Caroline Davin, Gabriel Haddad, Jacques Yb Khalil, Camille Blériot, François-Xavier Danlos, Garett Dunsmore, Kevin Mulder, Aymeric Silvin, Thibault Raoult, Baptiste Archambaud, Shaima Belhechmi, Ivo Gomperts Boneca, Nadège Cayet, Maryse Moya-Nilges, Adeline Mallet, Romain Daillère, Etienne Rouleau, Camelia Radulescu, Yves Allory, Jacques Fieschi, Mathieu Rouanne, Florent Ginhoux, Gwénaël Le Teuff, Lisa Derosa, Aurélien Marabelle, Jeroen van Dorp, Nick van Dijk, Michiel S Van Der Heijden, Benjamin Besse, Fabrice Andre, Miriam Merad, Guido Kroemer, Jean Yves Scoazec, Laurence Zitvogel, Yohann Loriot
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer. Cancer discovery 12 (10) (2022)